{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:33:30Z","timestamp":1793946810351,"version":"4.8.0"},"reference-count":0,"publisher":"Kare Publishing","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anatol J Cardiol"],"abstract":"<jats:p>Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome with substantial early morbidity and mortality. The BREATH2 score was recently developed as an echocardiography-independent screening tool for HFpEF. However, its prognostic significance has not been investigated. This study aimed to evaluate the association between the BREATH2 score and 1-year all-cause mortality in patients with established HFpEF.\n\nMethods: A total of 213 patients with HFpEF were retrospectively analyzed. The primary endpoint was 1-year all-cause mortality. Discriminative performance of the BREATH2, H2FPEF, and HFA-PEFF scores was assessed using receiver operating characteristic analysis. Multiple logistic regression was performed to identify independent predictors of mortality. Kaplan\u2013Meier survival analysis was conducted using a prespecified BREATH2 cut-off (\u22656).\n\nResults: During 12-month follow-up, 32 patients (15.0%) died. The BREATH2 score was significantly higher among non-survivors (P = .001). Receiver operating characteristic curve analysis demonstrated that BREATH2 had the highest discriminative ability for 1-year mortality (area under the curve [AUC] = 0.683, P &lt; .001, 95% CI: 0.616-0.745), outperforming H2FPEF (AUC = 0.554, P = .324) and HFA-PEFF (AUC = 0.593, P &lt; .001). In multiple analyses adjusting for age, creatinine, and N-terminal pro-B-type natriuretic peptide, \nBREATH2 remained independently associated with mortality (odds ratio = 1.658 per 1-point increase, P = .021, 95% CI: 1.078-2.551). Patients with BREATH2 \u22656 had significantly lower survival compared with those with lower scores(log-rank, P = .013).\n\nConclusion: The BREATH2 score independently predicts 1-year mortality in patients with HFpEF. Beyond its diagnostic role, BREATH2 may serve as a practical early risk stratification tool at initial clinical presentation.<\/jats:p>","DOI":"10.14744\/anatoljcardiol.2026.6689","type":"journal-article","created":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:20:27Z","timestamp":1793946027000},"source":"Crossref","is-referenced-by-count":0,"title":["The BREATH2 Score as an Independent Predictor of 1-Year Mortality in Patients with Heart Failure with Preserved Ejection Fraction"],"prefix":"10.14744","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2620-9948","authenticated-orcid":false,"given":"Halit\u00a0Emre","family":"Yalva\u00e7","sequence":"first","affiliation":[{"name":"Department of Cardiology, Eski\u015fehir City Hospital, Eski\u015fehir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1321-1512","authenticated-orcid":false,"given":"Ezgi\u00a0\u00c7aml\u0131","family":"Babayi\u011fit","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Eski\u015fehir City Hospital, Eski\u015fehir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4559-6541","authenticated-orcid":false,"given":"Hazal","family":"Da\u011fhan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Eski\u015fehir City Hospital, Eski\u015fehir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5966","published-online":{"date-parts":[[2026]]},"container-title":["The Anatolian Journal of Cardiology"],"original-title":[],"link":[{"URL":"https:\/\/file.paplino.com\/anatoljcardiol\/pdfs\/1787815996-en.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:20:27Z","timestamp":1793946027000},"score":1,"resource":{"primary":{"URL":"https:\/\/anatoljcardiol.com\/article\/AJC-80747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":0,"URL":"https:\/\/doi.org\/10.14744\/anatoljcardiol.2026.6689","relation":{},"ISSN":["2149-2271","2149-2263"],"issn-type":[{"value":"2149-2271","type":"print"},{"value":"2149-2263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}